Ecotoxicology Testing Market

ECOTOXICOLOGY TESTING MARKET TO 2031: SIZE, SHARE & GROWTH REPORT

The global ecotoxicology testing market is expected to value at USD 1.40 billion in 2026 and is projected to reach USD 1.74 billion by 2031, growing at a CAGR of approximately 4.4% during 2026–2031. Market growth is driven by increasing regulatory scrutiny of chemicals such as PFAS, evolving OECD ecotoxicity testing guidelines, and strengthening environmental risk assessment requirements for pesticides, industrial chemicals, and pharmaceuticals across major markets.

MARKET OVERVIEW

The Ecotoxicology Testing Market encompasses testing services, instruments, reagents & consumables, and software & data management solutions used to assess the potential adverse effects of chemicals and other regulated substances on organisms and ecosystems. The market covers aquatic, sediment, terrestrial plant & soil, avian, and pollinator & non-target arthropod testing conducted through in vivo, in vitro, in silico/computational, and field & mesocosm methods. Testing supports environmental risk assessments and regulatory submissions for agrochemicals, pharmaceuticals, industrial and specialty chemicals, and other regulated substances. The market excludes human and mammalian toxicology, clinical toxicology, occupational health testing, routine food and feed safety testing, general environmental monitoring without ecotoxicological endpoints, and medical-device biocompatibility testing.

Regulatory requirements remain a major factor supporting market demand. In March 2026, the European Chemicals Agency's (ECHA) Risk Assessment Committee adopted its final opinion on the proposed EU-wide PFAS restriction under REACH, while the Socio-Economic Analysis Committee advanced the proposal through its draft opinion. In July 2026, the OECD introduced new ecotoxicology Test Guidelines covering chronic oral toxicity in bumblebees and field effects on earthworms, while also updating its freshwater algae and cyanobacteria growth inhibition guideline. These developments highlight increasing regulatory attention to chemical persistence, environmental exposure, pollinator protection, and effects on terrestrial and aquatic organisms.

The market is supported by a global network of specialized testing organizations, including Eurofins Scientific, Charles River Laboratories, SGS, Intertek Group, Bureau Veritas, TÜV SÜD, ALS, Labcorp, Mérieux NutriSciences, and Smithers. Demand is increasingly favoring providers with GLP-compliant capabilities, broad organism and test-method expertise, higher-tier study capabilities, regulatory knowledge, and integrated data and computational solutions. Services held the largest share of the market in 2025, supported by the specialized infrastructure, biological expertise, and regulatory capabilities required to conduct ecotoxicology studies. During the forecast period, tighter chemical regulations, expanding environmental risk assessments, growing attention to pollinators and emerging contaminants, and increasing adoption of alternative and computational testing methods are expected to support market growth.

TOP 10 KEY TAKEAWAYS

• Europe held the largest share of the ecotoxicology testing market in 2025, supported by stringent chemical and environmental regulations, established GLP testing infrastructure, and strong demand for regulatory ecotoxicology studies.
• Asia Pacific is expected to be the fastest-growing regional market during 2026–2031, driven by expanding chemical, agrochemical, and pharmaceutical industries, strengthening environmental regulations, and growing testing capabilities across China, India, Japan, and South Korea.
• Aquatic ecotoxicology testing held the largest share by test type in 2025, supported by extensive regulatory requirements for assessing chemical effects on fish, aquatic invertebrates, algae, and other aquatic organisms. Pollinator & non-target arthropod testing is expected to register the highest CAGR, driven by increasing regulatory attention to bees and other beneficial insects.
• In vivo testing held the largest share by test method in 2025, as whole-organism studies remain integral to environmental risk assessment and regulatory submissions. In silico/computational testing is expected to be the fastest-growing method, supported by increasing adoption of QSAR, toxicokinetic/toxicodynamic modelling, and predictive ecological modelling.
• Fish held the largest share by organism type in 2025, reflecting their extensive use in acute, chronic, early-life-stage, and bioaccumulation studies. Pollinators are expected to be the fastest-growing organism segment, driven by increasing requirements for assessing effects on honeybees and other beneficial insects.
• Services held the largest share by offering in 2025, supported by demand for specialized GLP testing infrastructure, organism-handling expertise, study execution, regulatory interpretation, and dossier support. Software & data management is expected to be the fastest-growing offering, as laboratories increasingly adopt digital study management, data integration, and computational tools.
• Agrochemical & crop protection companies held the largest share among end users in 2025, owing to extensive ecotoxicity data requirements associated with pesticide registration and environmental risk assessment. Pharmaceutical & biotechnology companies are expected to register the highest CAGR, supported by expanding environmental risk assessment requirements for active pharmaceutical ingredients and their environmental residues.
• Increasing regulatory scrutiny of persistent and environmentally hazardous chemicals is expanding demand for ecotoxicology studies. In March 2026, ECHA's Risk Assessment Committee adopted its final opinion on the proposed EU-wide PFAS restriction under REACH, while the Socio-Economic Analysis Committee agreed its draft opinion, highlighting continued regulatory attention to persistence, environmental exposure, and ecological risks.
• OECD continues to expand internationally accepted ecotoxicology testing approaches. In July 2026, new Test Guidelines covering chronic oral toxicity in bumblebees and field effects on earthworms were introduced, while the freshwater algae and cyanobacteria growth inhibition guideline was updated, expanding standardized approaches for pollinator, terrestrial, and aquatic testing.
• Laboratory capacity, access to specialist organism expertise, and turnaround-time pressures remain important market challenges. Higher-tier chronic, field and mesocosm, pollinator, and specialized terrestrial studies require greater infrastructure, technical expertise, and longer study durations than many routine acute tests.

WHY ECOTOXICOLOGY TESTING MARKET MATTERS NOW

Chemical, agrochemical, and environmental safety regulations are placing greater emphasis on understanding the ecological effects, persistence, and environmental fate of regulated substances. In March 2026, ECHA's Risk Assessment Committee adopted its final opinion supporting an EU-wide restriction on PFAS, while the Socio-Economic Analysis Committee issued its draft opinion. The proposed restriction covers more than 10,000 PFAS substances across a broad range of industrial and consumer applications. At the same time, OECD continues to expand internationally accepted ecotoxicology testing approaches. In June 2025, it introduced a new acute contact toxicity guideline for mason bees and updated several fish and aquatic testing guidelines. In 2026, new Test Guidelines included chronic oral toxicity testing in bumblebees and field-effects testing in earthworms. In the US, EPA continues to update its Aquatic Life Benchmarks and maintains ecological-effects data requirements supporting pesticide registration and environmental risk assessment.

Ecotoxicology testing provides the scientific evidence needed to assess whether chemicals and other regulated substances may adversely affect aquatic and terrestrial organisms, pollinators, plants, and ecosystems. Regulatory scrutiny of PFAS, pesticides, industrial chemicals, pharmaceuticals, and other environmentally relevant substances is increasing demand for acute and chronic toxicity studies, bioaccumulation assessments, pollinator testing, sediment and terrestrial studies, and higher-tier field and mesocosm evaluations. As environmental risk assessments become broader and more data-intensive, demand is also increasing for GLP-compliant testing, specialized organism expertise, regulatory interpretation, and computational approaches that complement conventional whole-organism testing.

MARKET TRENDS SHAPING ECOTOXICOLOGY TESTING

A major trend is the broadening of regulatory testing from traditional acute endpoints toward chronic, life-stage, pollinator, sediment, and higher-tier terrestrial assessments. OECD continues to update its ecotoxicology framework to address these requirements. In June 2025, OECD updated key fish-related Test Guidelines, including Fish Acute Toxicity (TG 203), Fish Early-life Stage Toxicity (TG 210), and Fish Embryo Acute Toxicity (TG 236), while introducing a new acute contact toxicity test for mason bees (TG 254). In July 2026, OECD introduced chronic oral toxicity testing for bumblebees (TG 255) and a field-study guideline for assessing effects on earthworms (TG 256). These developments are increasing demand for laboratories capable of conducting chronic, developmental, pollinator, and higher-tier studies.

A second trend is the growing testing complexity associated with emerging contaminants and advanced materials. PFAS are receiving significant regulatory attention because of their environmental persistence and widespread use. In March 2026, ECHA's Risk Assessment Committee adopted its final opinion supporting an EU-wide PFAS restriction, while the Socio-Economic Analysis Committee agreed its draft opinion. The underlying restriction proposal covers more than 10,000 PFAS substances. Separately, in December 2025, OECD published the second edition of its Guidance Document on Aquatic and Sediment Toxicological Testing of Nanomaterials, providing updated recommendations for conducting reliable ecotoxicity studies with manufactured nanomaterials.

A third trend is the continued importance of pesticide registration and registration review in supporting ecotoxicology testing demand. In the US, EPA requires ecological-effects data for pesticide registration under 40 CFR Part 158, covering relevant aquatic and terrestrial organisms. In September 2025, EPA updated its Aquatic Life Benchmarks for registered pesticides, incorporating new and revised toxicity values used in ecological risk assessments. Continued registration, re-registration, and environmental risk assessment activities therefore support recurring demand for aquatic, terrestrial, pollinator, and environmental-fate studies.

A fourth trend is greater international harmonization of regulatory testing, which favors laboratories operating under OECD Test Guidelines and Good Laboratory Practice (GLP). Through the OECD Mutual Acceptance of Data (MAD) system, qualifying non-clinical safety studies generated in one participating country can be accepted for regulatory assessment in more than 40 other participating countries, subject to applicable GLP monitoring and product-scope requirements. This reduces unnecessary duplication of testing and increases the value of laboratories capable of supporting multinational chemical, agrochemical, and pharmaceutical submissions.

A fifth trend is investment in specialized testing capacity, particularly for terrestrial organisms, pollinators, and higher-tier studies. In July 2026, Smithers announced an expansion of its terrestrial ecotoxicology laboratory capacity in Harrogate, UK, including additional controlled plant-growth and incubator space for non-target plant, arthropod, and soil-organism testing. Such investments reflect increasing demand for GLP-compliant laboratories with specialist organism-handling expertise and the infrastructure required to support complex global regulatory studies.

MARKET DRIVERS ACCELERATING GROWTH

The first driver is the EU REACH PFAS restriction, which ECHA's RAC and SEAC advanced through final and draft opinions in March 2026, followed by a public consultation that closed on May 25, 2026. SEAC is expected to adopt its final opinion by the end of 2026. The proposed restriction covers more than 10,000 PFAS substances across industrial, consumer, and other applications, increasing regulatory attention to environmental persistence, exposure, and ecological risks and supporting demand for ecotoxicology testing.

The second driver is OECD's continued expansion and updating of its Test Guidelines Programme. In June 2025, OECD updated key fish-related Test Guidelines and introduced a new acute contact toxicity test for mason bees. In December 2025, OECD published updated guidance for aquatic and sediment toxicological testing of manufactured nanomaterials. In July 2026, OECD introduced seven new Test Guidelines, including chronic oral toxicity testing for bumblebees, field-effects testing in earthworms, and methods addressing properties of nanomaterials. These additions broaden the range of standardized testing approaches available for environmental hazard and risk assessment.

The third driver is sustained US regulatory demand for ecological-effects testing, particularly under FIFRA. EPA requires relevant ecological-effects and environmental-fate data under 40 CFR Part 158 to support pesticide registration and registration review. EPA also updates its Aquatic Life Benchmarks periodically, most recently in September 2025, using toxicity values from ecological risk assessments for registered pesticides. These recurring regulatory requirements support continued demand for aquatic, terrestrial, plant, wildlife, and non-target organism testing.

MARKET CHALLENGES AND RESTRAINTS

The most significant restraint is the high cost and long duration of chronic and higher-tier testing. As regulatory assessments increasingly incorporate chronic, reproductive, field, and other higher-tier ecological endpoints, study timelines, infrastructure requirements, and costs can increase substantially. For example, OECD's July 2026 guideline for assessing effects on earthworms under field conditions typically requires a one-year study period and may be extended depending on the properties of the test chemical or observed effects.

A second restraint is limited cross-jurisdiction harmonization outside the OECD Mutual Acceptance of Data framework. The MAD system facilitates acceptance of qualifying non-clinical safety data across OECD member countries and participating non-OECD countries. However, jurisdiction-specific chemical registration and environmental risk assessment requirements in markets such as the US, China, South Korea, and others mean global chemical and agrochemical sponsors must still manage differences in data requirements, study strategies, and regulatory submissions.

A third challenge is the analytical complexity of testing difficult substances and mixtures, including UVCBs and poorly soluble chemicals. Such substances can require specialized exposure preparation, analytical confirmation, and test-system expertise to accurately characterize exposure concentrations. A related challenge is access to specialist organisms and higher-tier testing capabilities. Studies involving pollinators, earthworms, sediment-dwelling organisms, and field or mesocosm systems require specialized infrastructure, organism-handling expertise, and trained scientific personnel, creating capacity and scheduling constraints for complex regulatory studies.

REPORT SCOPE

The market covers laboratory-based testing services and supporting technologies for aquatic, terrestrial, avian/pollinator, and sediment ecotoxicology, and nanomaterial/microplastics/PFAS ecotoxicity testing, along with the accredited testing organizations, in silico QSAR screening tools, and mixture-toxicity modeling that support regulatory submissions. Out of scope are human toxicology and clinical safety testing, general environmental chemical analysis not tied to ecological hazard endpoints, and the chemicals, pesticides, or products themselves. The market connects to the [INTERNAL LINK: environmental testing market], the [INTERNAL LINK: agrochemical testing market], the [INTERNAL LINK: PFAS testing and remediation market], the [INTERNAL LINK: in vitro toxicology testing market], and the [INTERNAL LINK: analytical laboratory services market].

MARKET SEGMENTATION

The ecotoxicology testing market is segmented by offering, test type, test method, organism type, end user, and region. By offering, the market includes products, services, and software & data management. By test type, the market covers aquatic ecotoxicology testing, sediment ecotoxicology testing, terrestrial plant & soil ecotoxicology testing, avian ecotoxicology testing, pollinator & non-target arthropod testing, and other test types. By test method, the market includes in vivo testing, in vitro testing, in silico/computational testing, field & mesocosm studies, and other test methods. By organism type, the market covers fish, aquatic invertebrates, algae & aquatic plants, sediment/benthic organisms, terrestrial invertebrates, pollinators, birds & other avian species. By end user, the market includes agrochemical & crop protection companies, pharmaceutical & biotech companies, chemical manufacturers, contract research organizations (CROs) & testing laboratories, government & regulatory agencies, and academic & research institutes. Regional coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

These segments are closely linked across the ecotoxicology testing ecosystem. For example, an agrochemical company may use aquatic, terrestrial, avian, or pollinator testing services to evaluate environmental safety, while analytical instruments, reference standards, in vivo or computational methods, and regulatory consulting support study execution and regulatory submissions across different regions.

SEGMENT INSIGHTS

By Offering

Services held the largest share of the ecotoxicology testing market in 2025, supported by strong demand for outsourced aquatic and terrestrial toxicity studies, regulatory study design, GLP-compliant testing, and dossier preparation across regulated industries.

Software & data management is expected to be the fastest-growing segment during the forecast period, driven by increasing adoption of predictive ecotoxicology, automated data analysis, digital study management, QSAR tools, and integrated regulatory data platforms.

By Test Type

Aquatic ecotoxicology testing held the largest share of the market in 2025, primarily due to extensive regulatory requirements for evaluating chemical effects on fish, aquatic invertebrates, algae, and other aquatic organisms across pesticides, pharmaceuticals, and industrial chemicals.

Pollinator & non-target arthropod testing is expected to be the fastest-growing segment during the forecast period, supported by increasing regulatory focus on honeybees, bumblebees, solitary bees, beneficial insects, chronic exposure, and sublethal ecological effects.

By Test Method

In vivo testing held the largest share of the market in 2025, reflecting its established role in regulatory environmental risk assessment and the continued requirement for whole-organism acute, chronic, reproductive, developmental, and bioaccumulation studies.

In silico/computational testing is expected to be the fastest-growing segment during the forecast period, driven by rising use of QSAR, read-across, category approaches, toxicokinetic/toxicodynamic modeling, and computational methods to reduce testing time, cost, and animal use.

By Organism Type

Fish held the largest share of the market in 2025, owing to their extensive use in standardized aquatic toxicity, chronic exposure, early-life-stage, reproductive, and bioaccumulation studies required for environmental hazard and risk assessment.

Pollinators are expected to be the fastest-growing segment during the forecast period, supported by expanding pesticide safety requirements, increasing attention to chronic and larval bee toxicity, and growing assessment of non-Apis pollinator and beneficial insect species.

By End User

Pharmaceutical & biotech companies held the largest share of the market in 2025, supported by increasing requirements to assess the environmental impact of active pharmaceutical ingredients, metabolites, and manufacturing-related chemical residues before and after product authorization.

Government & regulatory agencies are expected to be the fastest-growing end-user segment during the forecast period, driven by expanding environmental monitoring programs, stricter chemical safety requirements, and increasing assessment of emerging contaminants such as PFAS, pharmaceutical residues, and other persistent pollutants.

By Region

Europe

Europe held the largest share of the ecotoxicology testing market in 2025. The region benefits from stringent REACH requirements, mature GLP laboratory infrastructure, extensive agrochemical and chemical testing, and growing regulatory scrutiny of persistent substances. In March 2026, ECHA's Risk Assessment Committee adopted its final opinion on the proposed EU-wide PFAS restriction, reinforcing demand for environmental hazard, exposure, and ecotoxicological data.

North America

North America held the second-largest share of the ecotoxicology testing market in 2025. Growth is supported by stringent FIFRA and TSCA requirements, established GLP testing infrastructure, and increasing assessment of pesticides, industrial chemicals, PFAS, and other emerging contaminants. The US is the major contributor to the regional market. In September 2025, the US EPA updated its Aquatic Life Benchmarks to cover 782 pesticide chemicals and degradates and confirmed plans for annual updates, supporting recurring demand for aquatic toxicity and exposure testing.

Asia Pacific

Asia Pacific is expected to be the fastest-growing region during the forecast period. Growth is driven by expanding chemical, agrochemical, and pharmaceutical industries, strengthening chemical registration frameworks, increasing GLP testing capacity, and wider adoption of OECD-aligned methods. China, Japan, India, South Korea, and Australia are important regional markets. China's Ministry of Ecology and Environment has continued implementing new-chemical environmental management registrations and has developed guidance to standardize aquatic toxicity testing of difficult-to-test chemicals, strengthening demand for specialized ecotoxicology studies.

Latin America

Latin America represented an emerging ecotoxicology testing market in 2025, supported by a large agrochemical industry, increasing environmental risk assessment requirements, and growing demand for pesticide registration studies. Brazil is the major contributor to the regional market, with IBAMA requiring environmental safety assessments covering aquatic organisms, soil organisms, non-target species, persistence, and bioaccumulation. Ongoing refinement of Brazilian exposure scenarios for aquatic and soil organisms is further supporting demand for locally relevant ecotoxicology testing.

Middle East

The Middle East represents a developing ecotoxicology testing market, supported by expanding chemical and petrochemical industries, environmental monitoring programs, agricultural development, and strengthening environmental compliance requirements. Saudi Arabia and the UAE are among the key markets, with increasing investment in accredited laboratory infrastructure and environmental testing capabilities. Rising focus on chemical safety, wastewater monitoring, and industrial environmental impact assessment is expected to support gradual market expansion.

Africa

Africa held a relatively smaller share of the ecotoxicology testing market in 2025, supported by pesticide registration requirements, water-quality monitoring, agricultural chemical use, and increasing attention to contaminants of emerging concern. South Africa represents one of the more established markets due to its stronger regulatory and laboratory infrastructure. Growing research and monitoring of pharmaceuticals, microplastics, pesticides, and other contaminants in water and soil are expected to increase demand for ecotoxicological assessment across the region.

Key Segmentation Highlights

• Services held the largest share in 2025, while software & data management is expected to be the fastest-growing offering during the forecast period.
• Aquatic ecotoxicology testing held the largest share by test type, while pollinator & non-target arthropod testing is expected to grow fastest.
• In vivo testing held the largest share by test method, while in silico/computational testing is expected to be the fastest-growing segment.
• Fish held the largest share by organism type, while pollinators are expected to grow fastest during the forecast period.
• Pharmaceutical & biotech companies held the largest end-user share, while government & regulatory agencies are expected to grow fastest.
• Europe held the largest regional share, while Asia Pacific is expected to be the fastest-growing region.

KEY COMPANY INSIGHTS

The competitive landscape of the ecotoxicology testing market includes large testing, inspection & certification companies, global contract research organizations, and specialized environmental risk testing providers. Key companies considered in the market include Eurofins, Charles River Laboratories, SGS Société Générale de Surveillance SA, Intertek Group plc, Bureau Veritas, TÜV SÜD, ALS, Labcorp, Mérieux NutriSciences, and Smithers. Competition is primarily based on GLP-compliant testing capacity, breadth of aquatic and terrestrial test capabilities, organism expertise, analytical support, regulatory knowledge, geographic reach, and the ability to conduct higher-tier and customized studies.

• Eurofins (aquatic, terrestrial, pollinator, sediment, field/semi-field, and regulatory ecotoxicology studies)
• Charles River Laboratories (aquatic & terrestrial ecotoxicology, environmental risk assessment, endocrine testing, and regulatory support)
• SGS (freshwater, marine, soil & sediment ecotoxicology, biodegradability, and analytical testing)
• Intertek (aquatic & sediment toxicity, whole-effluent toxicity, TIE/TRE, and environmental risk assessment)
• Bureau Veritas (freshwater & marine toxicity, sediment testing, effluent monitoring, and customized ecotoxicology studies)
• TÜV SÜD (environmental testing, chemical compliance, and regulatory testing support)
• ALS (aquatic toxicity, whole-effluent toxicity, sediment toxicity, and environmental monitoring)
• Labcorp (aquatic & terrestrial ecotoxicology, pollinator studies, QSAR, environmental risk assessment, and analytical support)
• Mérieux NutriSciences (agrochemical ecotoxicology, environmental fate, toxicology, and regulatory support)
• Smithers (aquatic, sediment, terrestrial, pollinator, endocrine, and higher-tier ecotoxicology studies)

Eurofins is one of the most prominent players in the global ecotoxicology testing market, supported by its extensive Agroscience Services network and broad aquatic, terrestrial, pollinator, and higher-tier testing capabilities. In September 2025, Eurofins Agroscience Services acquired Cawood Scientific’s Agroscience research division, including businesses with ecotoxicology, environmental fate, residue, and field-study capabilities. The acquisition further strengthened Eurofins’ European environmental safety testing footprint and ability to support agrochemical and wider chemical-industry regulatory programs.

Labcorp maintains a strong position through purpose-built aquatic and terrestrial ecotoxicology facilities, integrated analytical chemistry, regulatory expertise, and extensive experience with crop protection and industrial chemicals. The company reports conducting more than 300 ecotoxicology studies annually and supports freshwater, marine, sediment, avian, terrestrial plant, soil-organism, and pollinator assessments. Its combination of conventional in vivo studies with QSAR and environmental risk assessment capabilities enables development of tiered, regulator-ready testing strategies.

Charles River Laboratories is differentiated by its integrated environmental safety offering covering aquatic and terrestrial ecotoxicology, environmental fate, endocrine disruption, analytical support, and regulatory risk assessment. Its services support agrochemicals, pharmaceuticals, biocides, and industrial chemicals across major regulatory frameworks, including REACH, EPA, EFSA, and pharmaceutical environmental risk assessments. The company also maintains specialized facilities capable of conducting standard and customized aquatic studies across fish, Daphnia, algae, microorganisms, and sediment organisms.

Key Company Strategy Conclusions

• Eurofins holds a strong competitive position through its extensive global laboratory network, broad agroscience/ecotoxicology capabilities, and ability to address chemical safety and emerging-contaminant testing requirements. Eurofins operates more than 950 laboratories across 57 countries.
• Charles River Laboratories and SGS benefit from broad testing capabilities, serving agrochemical, pharmaceutical, and chemical companies with integrated ecotoxicology, environmental safety, analytical, and regulatory-support services.
• Smithers competes through specialized ecotoxicology expertise, particularly in aquatic, sediment, terrestrial, pollinator, and higher-tier studies requiring species-specific technical capabilities.
• Intertek, Bureau Veritas, TÜV SÜD, and ALS compete through broad environmental testing capabilities, regulatory compliance expertise, accreditation coverage, and laboratory networks.
• Agrochemical registration, chemical safety regulations, environmental monitoring, and emerging-contaminant assessment are key demand drivers, translating regulatory requirements into recurring GLP testing, analytical, and regulatory-support revenue.

RECENT DEVELOPMENTS

• In July 2026, Smithers expanded its terrestrial ecotoxicology laboratory capacity in Harrogate, UK, adding purpose-built controlled plant-growth chambers and incubator space for non-target plants, arthropods, and soil organisms to increase GLP-compliant testing capacity.
• In September 2025, Eurofins Agroscience Services acquired Cawood Scientific’s Agroscience research division, including Innovative Environmental Services, Mambo-Tox, and i2L Research, strengthening its European ecotoxicology, environmental fate, residue analysis, and field-study capabilities.
• In September 2025, Intertek acquired Envirolab in Australia, expanding its environmental testing capabilities across soil, water, biological and chemical substances, PFAS, and other emerging contaminants.

REAL-WORLD USE CASES

Eurofins Environment Testing has expanded PFAS analytical capacity across North America, with more than 100 dedicated instruments supporting drinking water, contaminated-site, air, soil, sediment, tissue, and other environmental matrices. Its current testing portfolio can analyze up to 100 PFAS-related compounds using multiple regulatory and proprietary methods. This capability supports manufacturers, government agencies, wastewater operators, and environmental consultants in generating exposure and environmental-monitoring data for PFAS risk assessment and regulatory compliance.

Smithers provides ecotoxicology testing across more than 150 species, with capabilities covering fish, aquatic invertebrates, aquatic plants, bees and other arthropods, amphibians, and terrestrial organisms. Its laboratories routinely test challenging substances such as poorly soluble, volatile, highly sorptive, and hydrolytically unstable materials, while analytically confirming exposure concentrations down to the low parts-per-trillion range in sediment, soil, dietary, and aquatic matrices. These capabilities support regulatory programs for agrochemicals, pharmaceuticals, biocides, veterinary medicines, and industrial chemicals.

CONCLUSION AND FUTURE OUTLOOK

Through 2031, the ecotoxicology testing market is expected to grow steadily, supported by stricter chemical, agrochemical, pharmaceutical, and environmental safety regulations. Key growth drivers include the EU REACH framework and proposed PFAS restriction, evolving EPA FIFRA and TSCA requirements, and continued expansion of OECD ecotoxicology Test Guidelines. Rising focus on pollinators, aquatic and terrestrial organisms, and emerging contaminants is also increasing testing demand.

Future growth will be supported by greater adoption of in silico/computational methods, advanced analytical testing, higher-tier studies, and integrated data management. However, conventional in vivo studies will remain important for regulatory risk assessment. Testing providers with broad species coverage, GLP-compliant infrastructure, strong analytical capabilities, and regulatory expertise will be best positioned to benefit from expanding environmental safety requirements.

FREQUENTLY ASKED QUESTIONS (FAQ)

1. How big is the Ecotoxicology Testing market?

The Ecotoxicology Testing market is valued at USD 1.40 million in 2026 and is projected to reach approximately USD 1.74 million by 2031. Europe held the largest share in 2025, supported by stringent REACH requirements, established GLP testing infrastructure, and strong chemical and agrochemical testing activity.

2. What is the Ecotoxicology Testing market growth rate?

The market is forecast to grow at a CAGR of approximately 4.4% from 2026 to 2031. Asia Pacific is expected to be the fastest-growing region, driven by expanding chemical, agrochemical, and pharmaceutical industries, increasing GLP testing capacity, and strengthening environmental regulations.

3. Which segment leads the Ecotoxicology Testing market?

By offering, services held the largest share in 2025, while software & data management is expected to grow fastest. By test type, aquatic ecotoxicology testing held the largest share, while pollinator & non-target arthropod testing is expected to grow fastest. By test method, in vivo testing led the market, while in silico/computational testing is expected to record the highest growth.

4. Who are the key players in the Ecotoxicology Testing market?

Leading players include Eurofins, Charles River Laboratories, SGS, Intertek, Bureau Veritas, TÜV SÜD, ALS, Labcorp, Mérieux NutriSciences, and Smithers.

5. What are the factors driving the Ecotoxicology Testing market?

Major growth drivers include stringent REACH, FIFRA, and TSCA environmental safety requirements, expansion of OECD ecotoxicology Test Guidelines, increasing agrochemical and chemical registration activity, growing environmental risk assessment requirements, and rising monitoring of PFAS, pharmaceutical residues, pesticides, and other emerging contaminants.

SPEAK WITH OUR ANALYST

The ecotoxicology testing market is evolving as environmental regulations, chemical safety requirements, and ecological risk assessment needs become increasingly stringent across industries. Detailed analysis of test-type demand, organism-specific testing requirements, evolving OECD guidelines, regulatory frameworks, and laboratory capabilities can support informed decisions on testing strategy, CRO selection, regulatory planning, partnerships, and investment. MarketsandMarkets can help you go deeper: request a sample of the full study, speak with our analyst about your specific questions, or customize the scope to your target test types, methods, organism groups, end users, companies, and geographies. Reach out to explore how this intelligence can inform your ecotoxicology testing strategy, laboratory partner selection, or investment thesis.